Directly compressed matrices were produced using a binary mixture of different chitosan (CH) and xanthan gum (XG) ratios. These hydrophilic excipients were used to control the release of ambroxol HCl. CH and XG were investigated at three ratios of 1:1, 1:4 and 4:1. Mucosolvan LA® was used as a commercially available reference product. The optimal CH to XG ratio was 1:1 and the optimal drug to polymer ratio was 1:3. Matrix erosion, hydration and drug release studies were carried out using a dissolution apparatus (basket method). The release mechanism is also discussed
A sustained release matrix formulation for Ambroxol hydrochloride was designed and developed to achi...
Objective: The purpose of present study was to formulate oral sustained release matrix tablet of met...
AbstractThe objective of this study is to investigate the feasibility of using chitosan–sodium algin...
An oral controlled release (CR) matrix system of Ambroxol hydrochloride was developed using a binary...
Biopolymers such as chitosan and xanthan gum were applied as matrix component for fabrication into t...
The subject of our research is the optimization of direct compression (DC), controlled release drug ...
Biopolymers such as chitosan and xanthan gum were applied as matrix component for fabrication into t...
The development and evaluation of a controlled-release (CR) pharmaceutical solid dosage form compris...
The main objective is to formulate and evaluate the ambroxol Hcl sustained release matrix tablets fo...
The aim of the present study was to formulate and evaluate the matrix tablets containing chitosan ba...
The objective of the present investigation is to prepare Deacetylated Xanthan Gum, a new Xanthan Gum...
AbstractThe objective of this study is to develop chitosan–anionic polymers based extended-release t...
The objective of this study is to develop chitosan–anionic polymers based extended-release tablets a...
Objective: The purpose of this work was to develop and optimize the emulgel formulation of piroxicam...
In present study, an attempt has been made to evaluate the effect of natural gums on the release pro...
A sustained release matrix formulation for Ambroxol hydrochloride was designed and developed to achi...
Objective: The purpose of present study was to formulate oral sustained release matrix tablet of met...
AbstractThe objective of this study is to investigate the feasibility of using chitosan–sodium algin...
An oral controlled release (CR) matrix system of Ambroxol hydrochloride was developed using a binary...
Biopolymers such as chitosan and xanthan gum were applied as matrix component for fabrication into t...
The subject of our research is the optimization of direct compression (DC), controlled release drug ...
Biopolymers such as chitosan and xanthan gum were applied as matrix component for fabrication into t...
The development and evaluation of a controlled-release (CR) pharmaceutical solid dosage form compris...
The main objective is to formulate and evaluate the ambroxol Hcl sustained release matrix tablets fo...
The aim of the present study was to formulate and evaluate the matrix tablets containing chitosan ba...
The objective of the present investigation is to prepare Deacetylated Xanthan Gum, a new Xanthan Gum...
AbstractThe objective of this study is to develop chitosan–anionic polymers based extended-release t...
The objective of this study is to develop chitosan–anionic polymers based extended-release tablets a...
Objective: The purpose of this work was to develop and optimize the emulgel formulation of piroxicam...
In present study, an attempt has been made to evaluate the effect of natural gums on the release pro...
A sustained release matrix formulation for Ambroxol hydrochloride was designed and developed to achi...
Objective: The purpose of present study was to formulate oral sustained release matrix tablet of met...
AbstractThe objective of this study is to investigate the feasibility of using chitosan–sodium algin...